generated a B7-H3/IL-15 TriKE that used the scFv of the B7-H3-specific mAb 376.96; when deployed against PDAC, this TriKE resulted in a significant reduction in tumor load in vitro and in murine models (85). The gene discussed is CD276; the disease is neoplasm.